Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
5 Stocks That Moved the Market in January
06:20am, Monday, 06'th Feb 2023
These stocks illustrate the most important trends in the stock market right now.
Retirees: Don't fall for a popularity contest when it comes to your investments
05:12pm, Saturday, 04'th Feb 2023 MarketWatch
Fortune magazine is out with its latest ranking of the most admired companies
5 Best and Worst Performing Mega-Cap Stocks in January 2023
10:53pm, Friday, 03'rd Feb 2023
The stock market finished January on a positive note. This is a good sign for investors, who incurred huge losses last year.
Top 5 Health Care Stocks That May Rally
06:35pm, Friday, 03'rd Feb 2023 Benzinga
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go
Pfizer: The Covid Reset Makes Sense
04:00pm, Friday, 03'rd Feb 2023
Since the Cominarty vaccine is now arguably relegated to something similar to the seasonal flu shot with an expensive $130 retail price tag, it is unsurprising Mr. Market is bearish on the PFE stock.
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?
02:19pm, Friday, 03'rd Feb 2023 The Motley Fool
It's safe to go bargain-hunting again. Just make sure the bargain is a stock you actually want to own for the long haul.
Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits
02:19pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)
01:35pm, Friday, 03'rd Feb 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales
07:59pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Bristol-Myers' (BMY) fourth-quarter 2022 earnings beat estimates, while sales declined year over year due to generic erosion for oncology drug Revlimid.
Economic Data Deluge
04:04pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Economic Data Deluge.
Goldilocks Econ Data Presides Over Pre-Market
03:39pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
We haven't thrown around the term "Goldilocks" too much lately, but this morning, the shoe fits.
Pharma earnings: COVID ‘is highly uncertain for this year,' analyst says
02:36pm, Thursday, 02'nd Feb 2023
Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabeti
Got $1,000? 3 Cheap Stocks To Buy Right Now
12:54pm, Thursday, 02'nd Feb 2023 The Motley Fool
We may be entering a period of prolonged leadership from undervalued stocks, with these tickers poised to lead the charge.
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
11:10am, Thursday, 02'nd Feb 2023 The Motley Fool
Funneling money into this fund can drastically simplify your investing strategy.
